Current Events

CleanExBg is the only one b2b exhibition in Bulgaria, devoted on cleaning & hygiene products, detergents & technologies.
In 2017 the event continues working for its participants, but in a virtual exhibition format.
Next year it will be held again as a real-life event.

During its 2016 edition exhibitors from Italy, Netherlands and Bulgaria presented machines, chemicals, accessories for professional and domestic cleaning. The foreign participants considered their participation as a good opportunity for finding its distributor in Bulgaria and the local ones to show their latest products.

The advantages of the online b2b exhibition in brief: ● hussle-free participation ● new contacts and clients ● easy customers communication ● active presence on the internet and social media ● more traffic on your website
<< less

CleanExBg is the only one b2b exhibition in Bulgaria, devoted on cleaning & hygiene products, detergents & technologies.
In 2017 the event continues working for its participants, but in a virtual exhibition format.
Next year it will be held again as a real-life event.

During its 2016 edition more >>

For the third time in a row, the well-established and known event for sport and healthy life of Via Expo will be held.

The only difference in comparison to the previous two editions is in its virtual format this year. Its benefits are:
■ cost-effective participation ■ way to find distributors ■ no time restrictions ■ better market presence

The aim of Healthy Life'17 is to display and maintain the close relation between sport and health.

It provides an effective online platform for Bulgarian and international companies to present their products and services as well as to find new partners and clients. It targets manufacturers, importers and traders of healthy and organic foods, cosmetics, herbal and food supplements, holistic health, sports goods and equipment, halls equipment, etc.
<< less

For the third time in a row, the well-established and known event for sport and healthy life of Via Expo will be held.

The only difference in comparison to the previous two editions is in its virtual format this year. Its benefits are:
■ cost-effective participation ■ way to find distributors more >>

14th Pharmacovigilance 2017
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
9th November 2017, Kohinoor Continental Hotel, Mumbai, India

The Pharmacovigilance conference, organized yearly by Virtue Insight, is a unique event where key stakeholders gather with the aim of promoting patient safety and undertaking to continue work towards a more efficient pharmacovigilance system. This is the opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance.

KEY SPEAKERS:

• S SADHWANI, Drug controller of Maharashtra and Jt.Commissioner Drug, FDA
• K. BANGARURAJAN, Deputy Drugs Controller, DDC(I), CDSCO
• MUZAFFAR AHMAD, Member, Strategic Advisory Board on Health Millenium Alliance (Govt of India) and Member Council of India
• DAARA B. PATEL, Secretary General, Indian Drug Manufacturers' Association
• DEEPA ARORA, Vice President - Pharmacovigilance & Global Head - Drug Safety & Risk Management, Lupin
• JEAN-CHRISTOPHE DELUMEAU, Head of Pharmacovigilance Asia-Pacific, Bayer HealthCare (Singapore)
• MANISH VERMA, Director and Head of Medical Affairs, South Asia Zone, Sanofi
• SARABJEET KAUR, Associate Vice President- Pharmacovigilance, APCER Life Sciences
• AMBRISH SRIVASTAVA, Vice President: Medial Affairs,Clinical Research & Regulatory, Alkem Laboratories
• VIKRAM GOTA, Associate Professor, ACTREC, Tata Memorial Centre
• BHASWAT CHAKRABORTY, Senior VP & Chair, Research and Development Core Committee, Cadila
• AVINASH R. KAKADE, Senior Director and Head of Pharmacovigilance, Cipla
• SHUBHADEEP SINHA, Vice-President & Head (Global) - Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs
• RAHUL GUPTA, Vice President, Regulatory Affairs, USV
• SUJAY SURESH KULKARNI, Senior Manager, Medical and Regulatory Affairs, GSK
• MILIND ANTANI, Partner In-Charge - Pharma LifeSciences, Nishith Desai Associates
• ABHAY PHANSALKAR, Head Clinical Trials, Cipla
• DEEPTI SANGHAVI, Assistant Manager-Medical Writing, Tata Consultancy Services
• RUCHIKA SINGHAL, Business Unit Head, AstraZeneca
• GURPREET SINGH, Head of Vendor Management in PV, Novartis
• NIDHI VAISH DAS, Drug Safety, Roche Pharmaceuticals
• MANOJ SWAMINATHAN, Chief Manager / Head - Global Pharmacovigilance, Piramal
• SHASHIDHAR SWAMY, Project Manager, Tata Consultancy Services
• PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
• RAJANI ROKADE, Founder-Director, PharmaSoulz
• PRASHANT BODHE, Director, CliniSearch
Plus many more,,

WHO SHOULD ATTEND:

Vice Presidents, Directors, CRO’s, Heads and Managers of:
Pharmacovigilance Strategy, Drug Safety/Risk Management, Information and Clinical Data Management, Clinical Research, Research & Development, Product Safety/Assurance Assessment, Patient Safety & Outcomes Research & Data Analysis, Epidemiology project management, Regulatory Affairs and Compliance, Sales & Marketing, Biotech manufacturers
Pharmaceutical organizations, Generic pharmaceutical companies, Contract research organizations, Patient recruitment companies, Government- Department of health, Non-profit organizations/ Association, Consultants

CONFERENCE BOOKING DETAILS:-

Email – kavitha@virtueinsight.co.in or TEL: + 91 9940791115

• Early-Bird Discount until 26 September 2017 - 1 Delegate Pass – (INR 6,000 + GST (18%) per delegate).
• Standard Price from 27 September 2017– 1 or 2 Delegates – (INR 7,000 + GST (18%) per delegate).
• Group Discounts – 3 or 4 Delegates – (INR 6,500 + GST (18%) per delegate)
• Group Discounts – 5 and above Delegates – (INR 6,000 + GST (18%) per delegate)
• Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 + GST (18%) per delegate)
• Conference Sponsor & Exhibition Stalls are also available. We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.

REGISTRATION PROCESS:-
In order to register simply fill in the last page of the attached file and email us back to me or you can simply email me your invoice details in the below mentioned format;
• Company Name & Address:
• GST number (if applicable):
• Attendee Name:
• Job Title:
• Contact Number:

Be a part of this conference and explore benefit-risk management strategies and patient-centric approaches and how you can tackle the challenges of social media and drug safety legislation globally.

<< less

14th Pharmacovigilance 2017
“Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management”
9th November 2017, Kohinoor Continental Hotel, Mumbai, India

The Pharmacovigilance conference, organized yearly by Virtue Insight, is a unique more >>

The 43rd Society of Perfusion Scientists Annual Congress, Leeds 2017.

SCPS, or The Society of Perfusionists as it was previously known, was formed in 1974 and its main objectives are to promote the advancement of perfusion technology and to represent the interests of Clinical Perfusionists.

Overview:

HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by providing you with a structured and systematic series of questions about key compliance, risk management, internal auditing, and human resource management issues. As a process, HR audits are designed to help your organization identify potential and actual problem areas, help assess the effectiveness of current HR management activities, help assess weaknesses in HR internal control processes, and help assess human capital strategic and compliance related risks. HR audits should additionally provide suggestions for corrective action.
Importantly, HR audits should consider human capital related risks and opportunities from an enterprise risk management (ERM) perspective. That is, your HR Audits should take a holistic approach in assessing human capital risks and attempt to indicate the interrelationships and interactions between HR and other management and organizational issues.
Recognizing that no two employers are alike and that the practices, policies, and processes that may be appropriate and effective for multinational corporations may not be appropriate for small and medium size companies or non-profits, your HR audit activities should be designed to help your organization develop and tailor employment practices, policies, procedures, and processes to meet your specific needs. Your HR audit activities should first provide your organization with the "right" questions to ask about various employment practices issues; then helps you determine the optimal answer for your organization.
The HR audit areas in this program provide you with the right questions to ask about your human resource management activities. More importantly, it provides you with a positive method to identify and take corrective measures.

Why should you attend:

Numerous studies have identified the growing critical importance of human capital. Human capital determines that long term success of an organization. Human capital-and its management-- also represent significant liabilities. Managing this risk has become a critical activity for most organizations, and one that represents important opportunities.
Human capital risks can significantly threaten an organization and are routinely recognized for their negative impact on an organization. At the same time these risks are noted as "one of the risks least effectively managed." As noted, they are identified as risks that when improperly managed create significant strategic, financial, operational, and reputational risks. These risks threaten the management and sustainability of the organization and reduce it value.
As a result, organizations are bringing advanced techniques to the management of their human resources--this includes the use of HR auditing techniques. No longer merely checklists of do's and don'ts, HR audits have become a continuous, sustainable, comprehensive audit activity that assesses the governance, compliance, and management of the organization's human resources management practices, liabilities, and potential opportunities. HR audits increasing provide assurance that risks are properly identified and managed, that HR activities are aligned with organizational objectives, and that compliance and governance requirements are being met.
Many of our current management models were based on manufacturing - turning materials into products to sell. The environments were commonly production lines with expensive machinery and individuals had to be "at work" to produce.
This workshop reviews the current use of HR audits, reviews HR audit techniques, and discusses how HR Audits can be used to help the organization reduce risks and seize potential opportunities.

Who Will Benefit:

• HR Professionals
• CFOs
• Internal Auditors
• External Auditors
• Risk Managers
• Compliance Officers
• COOs

Agenda:

Day 1 Schedule

Lecture 1: Introduction to HR Audits
• Background of HR audits
• Evolution of HR audits
• Developing an HR audit plan
• Identifying key HR audit issues
Exercise: Pre-HR Audit Questionnaire
Lecture 2: Assessing Human Capital Risks
• Discussion of risk management issues
• Determining human capital risks
• Developing Key Risk Indicators (KRIs)
• Discussion of human capital risk mitigation and risk appetite
Exercise: The Employment Practices Liability Risk Assessment Tool
Exercise: Mapping capital human risks
Lecture 3: Developing HR Metrics
• Discussion of HR metrics
• Determining relevant human capital measures
• Developing Key Performance Indicators (KPIs)
• Developing HR audit dashboard
Lecture 4: HR Audit Model
• Discussion of the critical components of an HR audit
• Discussion of internal controls
• Discussion of internal audit activities
Exercise: The HR Audit Worksheet

Day 2 Schedule

Lecture 1: Assessing Strategic Alignment
• Assessing of the value of human capital
• Assessing your employment brand
• Assessing work force needs
• Assessing employee commitment and engagement
• Discussion of employee surveys to validate audit findings
Exercise: Mapping employee commitment
Lecture 2: Assessing HR Management Related Documents
• Assessing employment posters and notices
• Assessing job descriptions
• Assessing employee application and other hiring forms
• Assessing employee files
• Discussion of employee handbooks
Exercise: Review Survey Report on Employee Handbook Policies and Practices
Lecture 3: Assessing HR Management Processes and Practices
• Assessing the recruitment, selection and hiring process
• Assessing performance management
• Assessing employee relations
• Assessing the discipline and termination process
• Discussion of Technology
Lecture 4: Practical Applications of HR Audits
• Indentifying to HR audit stakeholders
• Discussion of HR audits for vendors, suppliers, and contractors
• Discussion of HR audits in mergers and acquisitions
• Discussion reporting and implementing HR audit results

Speaker
Ronald L. Adler
President, Laurdan Associates Inc.


Ronald L. Adler, president of Laurdan Associates Inc. has 42 years of HR consulting experience and has served as a consulting expert on work force, workplace, and HR management issues for The Wall Street Journal, HRMagazine, and other publications and newspapers across the country. Mr. Adler's research findings have been used by the Federal Reserve Board, the EEOC, the National Conference of State Legislatures, the National Federation of Independent Business (NFIB), insurers, and international organizations.
Mr. Adler is a frequent lecturer and author on HR management, employment practices, and UI issues. Mr. Adler is the author and editor of the Employment-Labor Law Audit (ELLA), the internationally recognized HR auditing and employment practices liability risk assessment process.
Mr. Adler is an adjunct professor at Villanova University where teaches a graduate level course in HR Auditing. Mr. Adler is also a certified instructor for The Chartered Property Casualty Underwriters (CPCU) Society on employment practices liability and HR auditing issues and has conducted continuing education courses for the American Institute of Certified Public Accountants (AICPA) and the Society for Human Resource Management (SHRM) on HR management and HR auditing topics. Additionally Mr. Adler has served as an adjunct instructor at the Baltimore City Community College on workplace diversity and sexual harassment.
Mr. Adler is an appointee to State of Maryland's Unemployment Insurance (UI) Oversight Committee and previously served as an appointee to the State's UI Funding Task Force, the UI Advisory Committee, and the state's Workforce Training Initiative. Mr. Adler has served as a moderator at the State of Maryland's Annual Human Relations Conference and at the state's Annual Small Business Conference.
Mr. Adler has assisted Congress and state legislatures develop employment and UI related legislation and has testified before the U.S. Senate H.E.L.P. Committee on genetic discrimination in the workplace and insurance.
Mr. Adler is a member of the Maryland Chamber's Employment Relations Committee and chairs the Chamber's UI subcommittee. Mr. Adler is also a member of the U.S. Chamber's Labor Relations Committee.


Location: Washington, DC Date: December 4th & 5th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: Courtyard Arlington Crystal City/Reagan National Airport 2899 Jefferson Davis Highway Arlington, VA 22202 USA


Price:
Price: $895.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $2,685.00 $4,475.00 You Save: $1,790.00 (40%)*
Register for 10 attendees Price: $4,922.00 $8,950.00 You Save: $4,028.00 (45%)*
Register now and save $200. (Early Bird)
Until October 31, Early Bird Price: $895.00 From November 01 to December 02, Regular Price: $1,095.00
Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901198SEMINAR?myeventflo-December-2017-SEO
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel


<< less

Overview:

HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by providing you with a structured and systematic series of questions about key compliance, risk management, internal auditing, more >>

Course "Quality by Design using Design of Experiments (QbD)" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:

This seminar focuses on how to establish a systematic approach to pharmaceutical development that is defined by Quality-by-Design (QbD) principles using design of experiments (DOE). In addition, this course teaches the application of statistics for setting specifications, assessing measurement systems (assays), developing a control plan as part of a risk management strategy, and ensuring process control/capability. All concepts are taught within the product quality system framework defined by requirements in regulatory guidance documents.
Using a QbD approach for pharmaceutical development studies should include a systematic understanding of the process and using this understanding to establish a control strategy as part of a comprehensive quality risk management program.
This systematic understanding should include both identification of significant process parameters and determination of a functional relationship (mathematical model) linking these significant process parameters to the critical quality attributes (CQAs). The original guidance document on pharmaceutical development provides general guidance on how these are identified: gaining knowledge about which variation in factors explains variation in product quality characteristics of drug product. It also provides a means to achieving this knowledge: through the use of formal experimental designs. The use of DOE methodology provides a means to identify those factors that impact product quality characteristics of drug product (or significant process parameters) and determine the functional relationship that links the process parameters to the CQAs.
Although the seminar focuses on the use of DOE for QbD, multiple aspects of QbD are integrated into the course. After learning the relevant applied statistics, participants will understand how statistics can be used to help set specifications and analyze measurement systems, two foundational requirements of QbD. Next participants will learn tools to help them get value out of their designed experiments. Then, participants will learn how to generate and analyze both screening and response surface designs for QbD studies. Lastly, participants will learn how to use this information: best practices on presentation, setting control plans, constructing control charts, and evaluating process capability.
Analyses in this course use the point-and-click interface of JMP software.

Why should you attend:

As stated in Q8, the ICH guidance document on pharmaceutical development, drug product should meet its intended product performance as well as meet the needs of patients. Although the strategy for pharmaceutical development may vary from company-to-company and/or from product-to-product, a systematic approach defined by quality by design (QbD) principles is encouraged.
Further guidance and policies have been provided to explain how the QbD approach should be integrated into the pharmaceutical quality system including process design, qualification, continued process verification, risk management, and validation. Although guidance on implementation of these requirements is prevalent, many companies have not yet implemented QbD into their quality systems; regulatory agencies have made it clear this will change. In fact, the chemistry, manufacturing, and controls (CMC) reviewers in the Office of Pharmaceutical Science (OPS) released a manual on policies and procedures (MAPP) explaining how reviewers will begin to enforce the requirements from these guidance documents. Additionally, the Director of the Center for Drug Evaluation and Research (CDER) at the FDA (May 2014) co-authored a paper in The American Association of Pharmaceutical Scientists detailing the concept and reiterating the importance of using a QbD approach to pharmaceutical development. This seminar will demonstrate how to integrate those QbD principles into a pharmaceutical quality system.

Areas Covered in the Session:

implement QbD principles from discovery through product discontinuation
apply statistics to set specifications and validate measurement systems (assays)
utilize risk management tools to identify and prioritize potential critical process parameters
identify critical process parameters and develop a functional relationship between those process parameters and your critical-to-quality attributes (CQAs)
establish your design space
develop a control plan as part of a risk management strategy
ensure your process is in (statistical) control and capable.

Who Will Benefit:

This seminar is designed for pharmaceutical and biopharmaceutical professionals who are involved with product and/or process design, validation, or manufacturing/control.
Process Scientist/Engineer
Design Engineer
Product Development Engineer
Regulatory/Compliance Professional
Design Controls Engineer
Six Sigma Green Belt
Six Sigma Black Belt
Continuous Improvement Manager

Agenda:

Day 1 Schedule

Lecture 1:
Introduction to Quality by Design (QbD)
Quality by Design (QbD) principles
Product Quality System framework
Primer on Statistical Analysis
basic statistics
Lecture 2:
Primer on Statistical Analysis (cont.)
hypothesis testing
Lecture 3:
Primer on Statistical Analysis (cont.)
ANOVA
Lecture 4:
Primer on Statistical Analysis (cont.)
Regression

Day 2 Schedule

Lecture 1:
Foundational Requirements for QbD Studies
setting specifications
Measurement Systems Analysis (MSA) for assays
Introduction to Design of Experiments (DOE)
steps to DOE
defining critical-to-quality attributes (CQAs)
identifying and prioritizing potential process parameters
Screening Designs - Identifying Critical Process Parameters
factorial designs
Lecture 2:
Screening Designs - Identifying Critical Process Parameters (cont.)
fractional factorial designs
D optimal
Lecture 3:
Response Surface Designs - Develop Functional Relationships and Establish Design Space
Addition of center points
Central Composite Designs (CCD)
I optimal designs
Lecture 4:
Utilizing Systematic Understanding from QbD Studies
presenting results
developing a control plan as part of a risk management strategy
process control and capability

Speaker
Heath Rushing
Co-founder and Principal, Adsurgo

Heath Rushing is the cofounder of Adsurgo LLC and co-author of the book Design and Analysis of Experiments by Douglas Montgomery: A Supplement for using JMP. Previously, he was the JMP and Six Sigma training manager at SAS. He led a team of nine technical professionals designing and delivering applied statistics and quality continuing education courses. He created tailored courses, applications, and long-term training plans in quality and statistics across a variety of industries to include biotech, pharmaceutical, medical device, and chemical processing. Mr. Rushing has been an invited speaker on applicability of statistics for national and international conferences. As a Quality Engineer at Amgen, he championed statistical principles in every business unit. He designed and delivered a DOE course that immediately became the company standard required at multiple sites. Additionally, he developed and implemented numerous innovative statistical methods advancing corporate risk management, process capability, and validation acceptance criteria. He won the top teaching award out of 54 instructors in the Air Force Academy math department where he taught several semesters and sections of OR and statistics. Additionally, he taught Operations Research and simulation modeling at the Colorado School of Mines and designs and delivers short courses in statistics, data mining, and simulation modeling for SAS.


Location: Boston, MA Date: December 4th & 5th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: Embassy Suites Boston Logan Airport 207 Porter St, Boston, MA 02128, USA

Price:
Price: $1,295.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Register now and save $200. (Early Bird)
Until October 20, Early Bird Price: $1,295.00 From October 21 to December 05, Regular Price: $1,495.00

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901134SEMINAR?myeventflo.-December-2017-SEO

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel


<< less

Course "Quality by Design using Design of Experiments (QbD)" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.
Overview:

This seminar focuses on how to establish a systematic approach to pharmaceutical development more >>

11th Biosimilars Congregation 2017
“Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
06th December 2017, Kohinoor Continental Hotel, Mumbai, India

Virtue insight is proud to present its 11th Biosimilars Congregation on 6th December 2017 at Kohinoor Continental Hotel, Mumbai, India. Discussing strategies for biosimilar product development Indian Pharmaceutical companies have started to look at biosimilars as a lucrative sector owing to the recent regulatory approvals and revenue generating opportunities. This event will discuss commercial strategies, insights on how regulatory & approval process work in region, opportunities for market expansion and highlights on R&D.

KEY SPEAKERS:

• MILIND NARVEKAR, Senior Director Generic Regulatory Affairs, Teva Pharmaceuticals
• SHUBHADEEP SINHA, Vice-President & Head (Global)- Clinical Development, Medical Affairs & Pharmacovigilance, Hetero Labs
• RAVISHANKAR KASTURI, Vice President - Development & Manufacturing, Reliance Life Sciences
• BINDU AJIT, Program Director, Biocon Academy
• HANMANT BARKATE, Vice President & Head Medical affairs & Clinical Research, Wockhardt
• SAMIR KULKARNI, Independent Biosimilars Professional Expert
• KIRAN KALAVADIA, Vice President, Cipla
• ANIL KUKREJA, Medical Director, Roche Pharmaceuticals
• LALIT LAKHWANI, Associate Director and Head of Clinical strategy, Dr. Reddy's Laboratories
• ANITA KRISHNAN, Assistant Director, Head Bioanalytical Team, Lupin
• SONIKA SHAH. Regulatory Affairs Head. Amgen
• VIJAY NAG THOTA, Head-Quality & Regulatory, SciGen BioPharma
• ALAP GANDHI, Head, Medical Affairs, Glaxo Smith Kline (GSK)
• KARAN THAKKAR, Regional Clinical Site Lead, Pfizer
• ROSHAN PAWAR, Senior Medical Advisor, Oncology, Alkem Laboratories
• SRIVANI MUKKAMALA, Independent Consultant
• PRASHANT BODHE, Director, CliniSearch

WHO SHOULD ATTEND:

CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists from the following roles:

Biopharmaceuticals/ Biotherapeutics, Follow on Biologics/Follow on Proteins, Biologics/Biotechnology/ Biogenerics, Legal Affairs, Intellectual Property,Health Economics, Pricing and Reimbursement, Clinical Immunology, Principal Scientist, Chief Scientific Officer, Process Control and Analytical Technologies, Analytical Characterisation, Regulatory Compliance, Pharmacovigilance, Drug Safety & Risk Management, Quality Affairs/ Quality Control, New Product Development, Process Science,Portfolio Management, Research & Development, Business Development, Business Operations, Scientific Affairs, Commercial Affairs

CONFERENCE REGISTRATION PROCESSS:

You can e-mail your interest to Kavitha@virtueinsight.co.in OR Tel- +91 44 64998743

• Early Bird Discounted Price (Until 24th October 2017) –- (INR 6,000 + GST (18%) per delegate)
• Standard Price (25th October 2017 Onwards) – (INR 7,000 + GST (18%) per delegate)
• Group Discounts – 3 or 4 Delegates - (INR 6,500 + GST (18%) per delegate)
• Group Discounts – 5 and above Delegates - (INR 6,000 + GST (18%) per delegate)
• Spot Registration on the day of the Conference -(INR 8,000 + GST (18%) per delegate)
• Conference Sponsor & Exhibition Stall or a paid Speaker Slots are also available.

In order to register you can simply e-mail me your invoice details in the below mentioned format;
E-mail- Kavitha@virtueinsight.co.in
• Name:
• GST Number (If Applicable):
• Company Name & Address:
• Job Position:
• Contact Number:

Join us to explore the current global climate for biosimilars, evaluate competition and benchmark with industry peers on how to navigate the changing regulations and landscape of the biosimilars market and effectively bring these programs to market.
<< less

11th Biosimilars Congregation 2017
“Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars”
06th December 2017, Kohinoor Continental Hotel, Mumbai, India

Virtue insight is proud to present its 11th Biosimilars Congregation more >>

Course "Data Integrity, 21 CFR 11 & Annex 11 Implementation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

The Problem:
We have all heard of Data Integrity but do you really understand what it is? Do you understand how 21 CFR 11 and Annex 11 fit into this picture? Specifically, can you answer questions on the following:
• Evolution of 21 CFR Part 11 and Annex 11 and Why they are Back in the News
• Overview and Key Requirements of Part 11 & Annex 11
• How to use a Risk Based Assessment to reduce work while still achieving Data Integrity and Compliance?
• How FDA & other Regulatory Authorities Inspect Computerized Systems for Data Integrity?
I often refer to 21 CFR 11 and Annex 11 as Good Software Engineering with the Documentation on Steroids! However, unless one knows how to implement Data Integrity, it is often very hard to apply requirements for DATA INTEGRITY to computerized system, and very hard to determine what needs to be done, to meet domestic and / or international regulations or business continuity requirements. In addition, the agencies have stepped up data integrity inspections and the number of citations on the subject are skyrocketing!
This course is appropriate for beginner and experienced person alike. The topics will build on each other and will give you the latest trends in our heavily regulated industry and how to make it easy for yourself while still achieving data integrity.
This is a very hands-on class and the attendees will be given take away templates that will enable them to build a complete package to meet Data Integrity Requirements for Computerized Systems

The Seminar:

This hands-on course will provide the attendees with more detailed experience on validation / 21 CFR 11 compliance of a computer system, as well as details for activities associated with computer systems validation as follows:
1. What is Data Integrity and how is it implemented
2. How to use Risk Based Assessments to reduce work while still achieving Data Integrity and Compliance?
3. Data Integrity Frequently Asked Questions
4. Validation Master Plan
5. Risk Based Asssessment
6. Complete Validation for a System (software development lifecycle)
7. Automated Test Tools
8. Infrastructure Requirements
9. Change Control
10. SOPs

Who Should Attend:

• VP of IT
• Director of IT
• Quality Managers
• Project Managers (for DATA INTEGRITY / IT)
• Validation Specialists
• Database Administrators
• System Administrators
• Directors / Senior Directors of Discovery
• Directors / Senior Directors of Development
• Directors / Senior Directors of Commercialization
• Document Managers
• Training Managers
• Consultants
• Data Managers
• Safety Managers

Agenda:

Day 1 Schedule

Lecture 1:
Introduction / Background
• Introductions / Participants' Understanding
• Participants' Objectives for the Course (Please come prepared to discuss)
Lecture 2:
Data Integrity
• What is Data Integrity
• How is it implemented
• Data Integrity Frequently Asked Questions
Lecture 3:
21 CFR 11 & Annex 11
• 21 CFR 11
• Annex 11
• 21 CFR 11.10(a) - Computer Systems Validation
Lecture 4:
Risk Assessment & Requirements
• Risk Assessment for Requirements
• Gathering Requirements
• Entity Relationship Diagram
• Process Decomposition
• Exercise on how to create Requirements

Day 2 Schedule

Lecture 1:
Design
• Design Specifications
• Software Configuration and Build
• Exercise on how to create Design Specifications
Lecture 2:
Verification & Testing
• Traceability Matrix
• Verification and Testing
• Other Documents
Lecture 3:
Special Topics
• Test Tools for DATA INTEGRITY
• Infrastructure Requirements
Lecture 4:
Change Control & SOPs
• Change Control
• SOPs

Speaker
Angela Bazigos
CEO, Touchstone Technologies Silicon Valley


Seasoned Executive with 40 years of experience in the Life Sciences & Healthcare Industries. Positions include Chief Compliance Officer http://morflearning.com/angelabazigos/. Experience combines Quality Assurance, Regulatory Compliance, Business Administration, Information Technology, Project Management, Clinical Lab Science, Turnarounds and Business Development. Past employers / clients include Roche, Novartis, Genentech & PriceWaterhouseCoopers. Co-authored & prototyped 21 CFR 11 guidance with FDA. Co-authored Computerized Systems in Clinical Research w/ FDA http://www1.diahome.org/~/media/4FA562336EBD46C58CDC43A8B7773095.ashx Patent on speeding up software compliance https://www.google.com/patents/US8266578. Recently quoted in Wall Street Journal for using training to bring regulatory compliance to the Boardroom http://blogs.wsj.com/riskandcompliance/2015/07/24/using-training-to-bring-compliance-to-boardrooms/ National Trainer for Society of Quality Assurance. Comments / collaborates with FDA on new guidance documents. Former President of Pacific Regional Chapter of Society of Quality Assurance. Stanford's Who's Who for LifeSciences: http://www.stanfordwhoswho.com/Angela.Bazigos.7144112.html#overview.

Location: SFO, CA Date: December 7th & 8th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: Hilton San Francisco Airport Bayfront 600 Airport Blvd, Burlingame, CA 94010, USA

Price:
Price: $1,495.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $4,485.00 $7,475.00 You Save: $2,990.00 (40%)*
Register for 10 attendees Price: $8,222.00 $14,950.00 You Save: $6,728.00 (45%)*
Register now and save $200. (Early Bird)

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901052SEMINAR?myeventflo-December-2017-SEO

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel


<< less

Course "Data Integrity, 21 CFR 11 & Annex 11 Implementation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

The Problem:
We have all heard of Data Integrity but do you really understand what more >>

Overview:

HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by providing you with a structured and systematic series of questions about key compliance, risk management, internal auditing, and human resource management issues. As a process, HR audits are designed to help your organization identify potential and actual problem areas, help assess the effectiveness of current HR management activities, help assess weaknesses in HR internal control processes, and help assess human capital strategic and compliance related risks. HR audits should additionally provide suggestions for corrective action.
Importantly, HR audits should consider human capital related risks and opportunities from an enterprise risk management (ERM) perspective. That is, your HR audits should take a holistic approach in assessing human capital risks and attempt to indicate the interrelationships and interactions between HR and other management and organizational issues.
Recognizing that no two employers are alike and that the practices, policies, and processes that may be appropriate and effective for multinational corporations may not be appropriate for small and medium size companies or non-profits, your HR audit activities should be designed to help your organization develop and tailor employment practices, policies, procedures, and processes to meet your specific needs. Your HR audit activities should first provide your organization with the "right" questions to ask about various employment practices issues; then helps you determine the optimal answer for your organization.
The HR audit areas in this program provide you with the right questions to ask about your human resource management activities. More importantly, it provides you with a positive method to identify and take corrective measures.

Why should you attend:

Numerous studies have identified the growing critical importance of human capital. Human capital determines that long term success of an organization. Human capital - and its management - can also create significant liabilities. Managing this risk has become a critical activity for most organizations; and one that represents important opportunities.
Human capital related risks can significantly threaten an organization and are routinely recognized for their negative impact on an organization. At the same time these risks are noted as "one of the risks least effectively managed." They are risks that when improperly managed create significant strategic, financial, operational, and reputational liabilities. As a result, these risks threaten the management and sustainability of the organization and reduce its value.
Thus, organizations are buying into advanced techniques to better manage their human resources - this includes the use of HR auditing techniques. No longer merely checklists of do's and don'ts, HR audits have become a continuous, sustainable, comprehensive audit activity that assesses the governance, compliance, and management of the organization's human resources management practices, liabilities, and potential opportunities. HR audits increasing provide assurance that risks are properly identified and managed; that HR activities are aligned with organizational objectives; and that compliance and governance requirements are being met.
This workshop reviews the current risk management risks, discusses the use of HR audits and HR audit techniques, and analyzes how HR audits can be used to help organizations reduce risks and seize potential opportunities.

Areas Covered in the Session:

• Review an overview of employment related risk management and HR Audits
• Assess human capital risks
• Develop HR metrics
• Explore the HR audit model
• Assess strategic alignment
• Assess HR management related documents
• Assess HR management processes and practices
• Review the practical applications of HR audits

Who will benefit:

• HR Professionals
• CFOs
• Internal Auditors
• External Auditors
• Risk Managers
• Compliance Officers
• COOs

Agenda:

Day 1 Schedule

Lecture 1:
Introduction to HR Audits
• Background of HR audits
• Evolution of HR audits
• Developing an HR audit plan
• Identifying key HR audit issues
Exercise: Pre-HR Audit Questionnaire
Lecture 2:
Assessing Human Capital Risks
• Discussion of risk management issues
• Determining human capital risks
• Developing Key Risk Indicators (KRIs)
• Discussion of human capital risk mitigation and risk appetite
Exercise: The Employment Practices Liability Risk Assessment Tool
Exercise: Mapping capital human risks
Lecture 3:
Developing HR Metrics
• Discussion of HR metrics
• Determining relevant human capital measures
• Developing Key Performance Indicators (KPIs)
• Developing HR audit dashboard
Lecture 4:
HR Audit Model
• Discussion of the critical components of an HR audit
• Discussion of internal controls
• Discussion of internal audit activities
Exercise: The HR Audit Worksheet

Day 2 Schedule

Lecture 1:
Assessing Strategic Alignment
• Assessing of the value of human capital
• Assessing your employment brand
• Assessing work force needs
• Assessing employee commitment and engagement
• Discussion of employee surveys to validate audit findings
Exercise: Mapping employee commitment
Lecture 2:
Assessing HR Management Related Documents
• Assessing employment posters and notices
• Assessing job descriptions
• Assessing employee application and other hiring forms
• Assessing employee files
• Discussion of employee handbooks
Exercise: Review Survey Report on Employee Handbook Policies and Practices
Lecture 3:
Assessing HR Management Processes and Practices
• Assessing the recruitment, selection and hiring process
• Assessing performance management
• Assessing employee relations
• Assessing the discipline and termination process
• Discussion of Technology
Lecture 4:
Practical Applications of HR Audits
• Indentifying to HR audit stakeholders
• Discussion of HR audits for vendors, suppliers, and contractors
• Discussion of HR audits in mergers and acquisitions
• Discussion reporting and implementing HR audit results

Speaker
Ronald L. Adler
President, Laurdan Associates Inc.


Mr. Ronald L. Adler, president of Laurdan Associates, Inc. has 42 years of HR consulting experience and has served as a consulting expert on work force, workplace, and HR management issues for The Wall Street Journal, HRMagazine, and other publications and newspapers across the country. Mr. Adler's research findings have been used by the Federal Reserve Board, the EEOC, the National Conference of State Legislatures, the National Federation of Independent Business (NFIB), insurers, and international organizations.
Mr. Adler is a frequent lecturer and author on HR management, employment practices, and UI issues. Mr. Adler is the author and editor of the Employment-Labor Law Audit (ELLA), the internationally recognized HR auditing and employment practices liability risk assessment process.
Mr. Adler is an adjunct professor at Villanova University where teaches a graduate level course in HR Auditing. Mr. Adler is also a certified instructor for The Chartered Property Casualty Underwriters (CPCU) Society on employment practices liability and HR auditing issues and has conducted continuing education courses for the American Institute of Certified Public Accountants (AICPA) and the Society for Human Resource Management (SHRM) on HR management and HR auditing topics. Additionally Mr. Adler has served as an adjunct instructor at the Baltimore City Community College on workplace diversity and sexual harassment.
Mr. Adler has served as an appointee to State of Maryland's Unemployment Insurance (UI) Oversight Committee and previously served as an appointee to the State's UI Funding Task Force, the UI Advisory Committee, and the state's Workforce Training Initiative. Mr. Adler has additionally served as a moderator at the State of Maryland's Annual Human Relations Conference and at the state's Annual Small Business Conference.
Mr. Adler has assisted Congress and state legislatures develop employment and UI related legislation and has testified before the U.S. Senate H.E.L.P. Committee on genetic discrimination in the workplace and insurance.
Mr. Adler formerly served as a member of the Maryland Chamber's Employment Relations Committee and chaired the Chamber's UI subcommittee. Mr. Adler also served as a member of the U.S. Chamber's Labor Relations Committee.
Mr. Adler is a member of the Society for Human Resource Management (SHRM) and previously served on SHRM's Human Capital Measurement/HR Metrics Special Expertise Panel. Mr. Adler additionally has served as a consulting expert on workplace issues to SHRM's legislative staff and has represented SHRM in meetings with the EEOC. Mr. Adler is also a member of the Institute of Internal Auditors.

Location: Boston, MA Date: December 7th & 8th, 2017 and Time: 8:30 AM to 4:30 PM
Venue: Embassy Suites Boston Logan Airport 207 Porter St, Boston, MA 02128, USA

Price:
Price: $1,095.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $3,285.00 $5,475.00 You Save: $2,190.00 (40%)*
Register for 10 attendees Price: $6,022.00 $10,950.00 You Save: $4,928.00 (45%)*
Register now and save $200. (Early Bird)
Until October 31, Early Bird Price: $1,095.00 From November 01 to December 05, Regular Price: $1,295.00

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901201SEMINAR?myeventflo-December-2017-SEO
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel


<< less

Overview:

HR audits are designed to help your organization focus its attention on its human resource management practices, policies, procedures, processes, and outcomes by providing you with a structured and systematic series of questions about key compliance, risk management, internal auditing, more >>

Course "Regulatory Requirements and Principles for Cleaning Validation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

This 2 day course will cover practical guidance on cleaning validation regulatory compliance, in conjunction with, risk-based, reasonable and informed decision making and activity planning. This two day interactive course will cover fundamental principles of a cleaning validation program, exploring such concepts as the determination of residues to be targeted, selection of analytical and sampling methods, determination of appropriate limits in various pharmaceutical and biotechnology processes, and establishment of scientific rationales acceptable to regulatory inspectors.
The program will describe the requirements for establishing an effective cleaning validation program, including the development of a general policy, a "Cleaning Validation Master Plan" and the appropriate documentation for each study to be performed. In addition, requirements for maintenance of the validated status will be reviewed. Regulatory requirements and the latest industry practices will also be included in the discussion.

Why you should attend:

Attendance at 2day seminar will be beneficial to personnel directly involved in the development of cleaning procedures, cleaning validation programs and plans. Additionally, those responsible for cleaning validation protocols and execution activities, including validation and laboratory personnel, as well as, beginning or seasoned operational personnel who will eventually participate in such efforts, will find this course particularly useful. This includes Analytical Method Development, Quality Control and Quality Assurance personnel.
Individuals in management who interact with the above or communicate with regulatory agency inspectors to rationalize or defend cleaning validation programs will also benefit from attending this course. There are no prerequisites for attending, but a basic knowledge of general science and equipment cleaning processes is helpful.

Areas Covered in the Session:

• Understand the importance and underlying principles of cleaning validation and the requirements to have adequate cleaning procedures for manufacturing equipment in contact with the product
• Understand the FDA perspectives on cleaning validation and areas of concern during regulatory inspections
• Be able to set up cleaning validation procedures, protocols and reports that meet current FDA, WHO, PIC/S and EU regulations
• Prepare and defend your own cleaning validation approach/program and avoid costly delays and/or rejections by regulatory agencies

Who Will Benefit:

Attendance at 2day seminar will be beneficial to personnel directly involved in the development of cleaning procedures, cleaning validation programs and plans. Additionally, those responsible for cleaning validation protocols and execution activities, including validation and laboratory personnel, as well as, beginning or seasoned operational personnel who will eventually participate in such efforts, will find this course particularly useful. This includes Analytical Method Development, Quality Control and Quality Assurance personnel.
Individuals in management who interact with the above or communicate with regulatory agency inspectors to rationalize or defend cleaning validation programs will also benefit from attending this course. There are no prerequisites for attending, but a basic knowledge of general science and equipment cleaning processes is helpful.
• Senior Quality Managers
• Quality Professionals
• Production Supervisors
• Validation Engineers
• Process Owners
• Quality Engineers
• Quality Auditors

Agenda:

Day 1 Schedule

Lecture 1:
FDA Requirements and Industry Standard Practices
Lecture 2:
How to Develop/Review your Cleaning Procedures and the Adequate Selection of Cleaning Agents and Parameters
Lecture 3:
How to Develop a Cleaning Validation Policy/Program
Lecture 4:
How to Implement a Robust Cleaning Validation Plan

Day 2 Schedule

Lecture 1:
Laboratory Issues in Cleaning
Lecture 2:
Microbiological aspects of a cleaning validation program for manufacturing equipment
Lecture 3:
Keys to Cleaning Validation Maintenance - Remaining Compliant
Lecture 4:
Current FDA concerns about validation of cleaning processes

Speaker
Joy McElroy
Principle Consultant, Maynard Consulting Company


Upon earning a degree in Zoology at North Carolina State University, Joy made her debut in the pharmaceutical industry in 1992 at Pharmacia & Up John performing Environmental Monitoring and Sterility Testing. Her hard work allowed her to move into a supervisory role at Abbott Laboratories where she oversaw their Quality Control Lab.
Now with 12 years experience as a consultant, and over 20 years total experience in the pharmaceutical and biotech industries, Joy has gained extensive knowledge of Quality Assurance, Process and Cleaning Validation, and Equipment Qualification. She has written and executed Equipment Qualification and Validation Protocols for numerous Companies such as Mallinckrodt, Wyeth Lederle, Merck, BioMerieux, Catalent, Phillips Medisize, Xcelience, and Novartis.
Joy specializes in Equipment Qualification, Cleaning Validation,Sterilization, Environmental Monitoring, and GMP Compliance Auditing.

Location: San Diego, CA Date: December 7th & 8th, 2017 and Time: 9:00 AM to 6:00 PM
Venue: DoubleTree by Hilton San Diego Downtown 1646 Front St, San Diego, CA 92101, USA

Price:
Price: $1,495.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $4,485.00 $7,475.00 You Save: $2,990.00 (40%)*
Register for 10 attendees Price: $8,222.00 $14,950.00 You Save: $6,728.00 (45%)*
Register now and save $200. (Early Bird)

Sponsorship Program benefits for “Quality Assurance Auditing for FDA Regulated Industry” seminar
At this seminar, world-renowned FDA Regulated Industry subject matter experts interact with CXO’s of various designations. Executives who carry vast experience about FDA Regulated Industry and Experts get down to discussing industry-related best practices, regulatory updates, changes in technologies, and much more relating to FDA Regulated Industry.
As a sponsor of these seminars, you get the opportunity to have your product and company reach out to C-Level executives in FDA Regulatory -related industries and become known among these elite executives and subject matter experts. Apart from being seen prominently at these globally held seminars, you also get talked about frequently in our correspondences with our experts and these participants.
For More Information- https://www.globalcompliancepanel.com/control/sponsorship

Contact us today!

NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901170SEMINAR?myeventflo-December-2017-SEO

Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel

<< less

Course "Regulatory Requirements and Principles for Cleaning Validation" has been pre-approved by RAPS as eligible for up to 12 credits towards a participant's RAC recertification upon full completion.

Overview:

This 2 day course will cover practical guidance on cleaning validation regulatory more >>

Aimed at surgeons, anaesthetists, nurses, surgical care practitioners, physiotherapists, child governance leads, database managers and allied health professionals.

The Save the Planet exhibition showcases local and foreign companies, who offer products and solutions for waste collection, treatment and utilization. A conference on the same topics will take place parallel to the exhibition. The event is open to representatives of municipalities and government administration, ecologists, investors, managers of companies from the sectors recycling, waste management, agriculture, food and packaging, etc. << less

The Save the Planet exhibition showcases local and foreign companies, who offer products and solutions for waste collection, treatment and utilization. A conference on the same topics will take place parallel to the exhibition. The event is open to representatives of municipalities and government administration, more >>

Smart Cities aims to popularize modern technologies and practices that can turn our cities into more eco-friendly and effective systems. It is a meeting point for solution providers and consumers. The parallel conference offers a chance to obtain information on current trends, legislation and perspectives. Among the event participants are companies offering solutions for passive houses, public transport innovations, energy efficient lighting, software for smart buildings and industry, etc. << less

Smart Cities aims to popularize modern technologies and practices that can turn our cities into more eco-friendly and effective systems. It is a meeting point for solution providers and consumers. The parallel conference offers a chance to obtain information on current trends, legislation and perspectives. more >>

BSP Spring Meeting Aberystwyth 2018.

Vascular Surgery 2018 Conference highlights the theme “Disseminating latest technologies in the field of Vascular & Endovascular Surgery”. Vascular Surgery 2018 is an event intended to provide an exclusive platform for new researchers, scholars, vascular surgeons, physicians, students and educators to present and discuss the most recent innovations, trends, and concerns, practical trials faced and the solutions adopted in the concerned field. The two days of educational program will include keynote presentations, oral presentations, and poster presenters on the advanced techniques as well as papers in the field of Vascular diseases, arteries, veins and lymphatic circulation, minimally-invasive catheter procedures, Surgery for Veins and Lymphatic Diseases, Vascular Imaging & Endovascular surgeries. << less

Vascular Surgery 2018 Conference highlights the theme “Disseminating latest technologies in the field of Vascular & Endovascular Surgery”. Vascular Surgery 2018 is an event intended to provide an exclusive platform for new researchers, scholars, vascular surgeons, physicians, students and educators more >>

Conference Series LLC welcomes you to attend the 12th International Conference and Exhibition on Structural and Molecular Biology during May 28-30, 2018 in Osaka, Japan. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The main theme of the conference is “A spectrum of Innovative Approaches and Solutions to Structural Biology”.
Hosted by Conference Series LLC, USA this event encourages sessions on the topics like Structure Determination, Computational Approaches, Single molecules, Molecular Biology, Sequencing, Signaling Biology, Molecular Dynamics, Drug Designing, Cancer Research, Bioinformatics, Complexity Arenas, Recent Advances in Structural and Molecular Biology field and more.
<< less

Conference Series LLC welcomes you to attend the 12th International Conference and Exhibition on Structural and Molecular Biology during May 28-30, 2018 in Osaka, Japan. This is an excellent opportunity for the delegates from Universities and Institutes to interact with the world class Scientists. The more >>